Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Zhu FC, et al. Among authors: zhang z, zhang j. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20. Lancet. 2020. PMID: 32702299 Free PMC article. Clinical Trial.
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Zhu F, Zhuang C, Chu K, Zhang L, Zhao H, Huang S, Su Y, Lin H, Yang C, Jiang H, Zang X, Liu D, Pan H, Hu Y, Liu X, Chen Q, Song Q, Quan J, Huang Z, Zhong G, Chen J, Han J, Sun H, Cui L, Li J, Chen Y, Zhang T, Ye X, Li C, Wu T, Zhang J, Xia NS. Zhu F, et al. Among authors: zhang l, zhang t, zhang j. Lancet Respir Med. 2022 Aug;10(8):749-760. doi: 10.1016/S2213-2600(22)00131-X. Epub 2022 May 26. Lancet Respir Med. 2022. PMID: 35644168 Free PMC article. Clinical Trial.
Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, Deen J, Acosta CJ, Chen Y, Wang H, Galindo CM, Ochiai L, Park T, von Seidlein L, Xu ZY, Clemens JD. Zhou WZ, et al. Among authors: zhang j. Pediatr Infect Dis J. 2007 Nov;26(11):1001-5. doi: 10.1097/INF.0b013e31812565bc. Pediatr Infect Dis J. 2007. PMID: 17984806 Clinical Trial.
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.
Hu YM, Guo M, Li CG, Chu K, He WG, Zhang J, Gu JX, Li J, Zhao H, Wu XH, Lin B, Lin ZJ, Yao XM, Li YF, Wei F, Huang Y, Su YY, Zhu FC, Huang SJ, Pan HR, Wu T, Zhang J, Xia NS. Hu YM, et al. Among authors: zhang j. Sci China Life Sci. 2020 Apr;63(4):582-591. doi: 10.1007/s11427-019-9547-7. Epub 2019 Jun 21. Sci China Life Sci. 2020. PMID: 31231780 Free PMC article.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Zhao FH, Wu T, Hu YM, Wei LH, Li MQ, Huang WJ, Chen W, Huang SJ, Pan QJ, Zhang X, Hong Y, Zhao C, Li Q, Chu K, Jiang YF, Li MZ, Tang J, Li CH, Guo DP, Ke LD, Wu X, Yao XM, Nie JH, Lin BZ, Zhao YQ, Guo M, Zhao J, Zheng FZ, Xu XQ, Su YY, Zhang QF, Sun G, Zhu FC, Li SW, Li YM, Pan HR, Zhang J, Qiao YL, Xia NS. Zhao FH, et al. Among authors: zhang qf, zhang j, zhang x. Lancet Infect Dis. 2022 Dec;22(12):1756-1768. doi: 10.1016/S1473-3099(22)00435-2. Epub 2022 Aug 26. Lancet Infect Dis. 2022. PMID: 36037823 Clinical Trial.
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS. Qiao YL, et al. Among authors: zhang j, zhang x, zhang wh. J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074. J Natl Cancer Inst. 2020. PMID: 31086947 Free PMC article. Clinical Trial.
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Zhuang CL, Lin ZJ, Bi ZF, Qiu LX, Hu FF, Liu XH, Lin BZ, Su YY, Pan HR, Zhang TY, Huang SJ, Hu YM, Qiao YL, Zhu FC, Wu T, Zhang J, Xia NS. Zhuang CL, et al. Among authors: zhang ty, zhang j. Emerg Microbes Infect. 2021 Dec;10(1):365-375. doi: 10.1080/22221751.2021.1891002. Emerg Microbes Infect. 2021. PMID: 33583360 Free PMC article. Clinical Trial.
The first Chinese national standards for SARS-CoV-2 neutralizing antibody.
Guan L, Yu Y, Wu X, Nie J, Zhang J, Wang Z, Li N, Shi R, Zhao H, Chen H, Luo C, Hu Y, Wang Y, Huang W, Xu M, Hou J. Guan L, et al. Among authors: zhang j. Vaccine. 2021 Jun 23;39(28):3724-3730. doi: 10.1016/j.vaccine.2021.05.047. Epub 2021 May 19. Vaccine. 2021. PMID: 34059373 Free PMC article.
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Su YY, Lin BZ, Zhao H, Li J, Lin ZJ, Qiao YL, Wei LH, Hu YM, Li RC, Zhuang SJ, Sun G, Zheng ZZ, Huang SJ, Wu T, Zhang J, Pan HR, Li CG. Su YY, et al. Among authors: zhang j. Hum Vaccin Immunother. 2020 Jul 2;16(7):1636-1644. doi: 10.1080/21645515.2019.1691413. Epub 2019 Nov 26. Hum Vaccin Immunother. 2020. PMID: 31770068 Free PMC article. Clinical Trial.
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Yu XJ, Li J, Lin ZJ, Zhao H, Lin BZ, Qiao YL, Hu YM, Wei LH, Li RC, Huang WD, Wu T, Huang SJ, Li CG, Pan HR, Zhang J. Yu XJ, et al. Among authors: zhang j. Hum Vaccin Immunother. 2020 Jul 2;16(7):1630-1635. doi: 10.1080/21645515.2020.1761202. Epub 2020 Jun 16. Hum Vaccin Immunother. 2020. PMID: 32544361 Free PMC article. Clinical Trial.
164,236 results
You have reached the last available page of results. Please see the User Guide for more information.